about
Germline mutations in BAP1 predispose to melanocytic tumorsMapping of balanced chromosome translocation breakpoints to the basepair level from microdissected chromosomes.Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice.Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Circulating tumor DNA as a liquid biopsy for cancer.The dynamic range of circulating tumor DNA in metastatic breast cancerMultiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention.D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.Circulating tumor cells and DNA as liquid biopsies.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsiesRapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.High-resolution analysis of alterations in medullary thyroid carcinoma genomes.Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.Single circulating tumor cell sequencing for monitoring.Inferring expressed genes by whole-genome sequencing of plasma DNA.Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.Co-occurrence of MYC amplification and TP53 mutations in human cancer.Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.Inferring expressed genes by whole-genome sequencing of plasma DNAToward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline MutationsExtra phenotypic features in a girl with Miller syndromeInference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detectionPublisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
P50
Q24594891-E91CABB7-8B5C-454D-AE96-0313F6A15A5EQ30985103-CD0839A6-E548-452C-BF1C-BC187937FA32Q33837122-57BFB7D5-62A7-472C-9E00-44B6DBEF52BEQ34322575-7A9A1393-17A2-47AF-9C89-BCE4A56F1C95Q34427193-97F73FFD-6A28-46BF-A1D9-4F9364C063E3Q34447436-0B1958A4-818C-4D61-888B-A6E20630CF62Q35000808-3DECC241-CE99-4906-8EDC-0D7E78364C65Q35077001-A14B0423-8E10-4A19-B328-3C70154FDE4BQ35133788-07474FA6-907A-46DF-A95D-465EA31D6C61Q35853245-A8DBA84B-AC47-465F-8A94-FD860F88A301Q35889016-8E4ADE01-23D7-4621-BE5A-3196D243F4D8Q36998629-2AF0B7B7-824F-443E-8DE0-A19FF9E9BEE4Q38133673-363C3727-80DB-4E2D-A23B-858B9BA5B1D0Q38700222-2CD9C77C-6F54-4D72-A9FB-17EF13BABB42Q38884073-E3B48324-ABC1-4533-B969-6D49BBA5315BQ39450576-F2BF0853-55C2-4387-A8FE-30E159297895Q41868457-2703CBA9-FE6B-4941-AF0F-E164B0884949Q42576747-5D824C64-FDA2-4B91-AE1C-4D6FB65566E6Q42774378-D66E5B49-6FF5-4F3C-AD7B-3FD11080F9B8Q46302330-AAB434F0-DCC4-471C-BB74-0BDC2CAAC022Q48166295-B7760D21-6A7F-410B-8039-D8A5B9085FAFQ48179788-0F0C4709-5166-4F7E-95AB-189534859675Q48253543-198FA3D6-519A-4D12-98EA-23EBA720B8A0Q48292408-50E0A2CA-6F89-4596-B0EB-B98770DB3AA9Q52637922-D6F45AEC-C2B7-4448-86E6-5C8E5813C9C5Q52843159-786A6089-473B-40AE-A08A-FCDF3B861B6BQ53165668-F01B72AC-5A87-4819-8ECE-6D358A3A802CQ57027547-C66EE2B6-E9C4-4139-954D-A26B97C55F9AQ57631287-840DE2A5-E099-4AF3-BC79-E4219F800767Q57636593-A45D4E95-AA53-4EA4-B52B-B22D0CAA3980Q90662922-4CC6FDF3-4671-4198-B809-4CAB43BC3139Q92093851-5F668BC7-2D25-4698-BE92-E0ABDF5D7013
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Peter Ulz
@ast
Peter Ulz
@en
Peter Ulz
@es
Peter Ulz
@nl
Peter Ulz
@sl
type
label
Peter Ulz
@ast
Peter Ulz
@en
Peter Ulz
@es
Peter Ulz
@nl
Peter Ulz
@sl
prefLabel
Peter Ulz
@ast
Peter Ulz
@en
Peter Ulz
@es
Peter Ulz
@nl
Peter Ulz
@sl
P1053
B-7528-2014
P106
P1153
36505137300
P21
P31
P3829
P496
0000-0001-5941-1160